Human thyroid papillary carcinomas are characterized by rearrangements of the RET protooncogene with a number of heterologous genes, which generate the RET/papillary thyroid carcinoma (PTC) oncogenes. One of the most frequent variants of these recombination events is the fusion of the intracellular kinase-encoding domain of RET to the first 101 amino acids of a gene named H4(D10S170). We have characterized the H4(D10S170) gene product, showing that it is a ubiquitously expressed 55 KDa nuclear and cytosolic protein that is phosphorylated following serum stimulation. This phosphorylation was found to depend on mitogen-activated protein kinase (MAPK) Erk1/2 activity and to be associated to the relocation of H4(D10S170) from the nucleus to the cytosol. Overexpression of the H4(D10S170) gene was able to induce apoptosis of thyroid follicular epithelial cells; conversely a carboxy-terminal truncated H4(D10S170) mutant H4(1-101), corresponding to the portion included in the RET/PTC1 oncoprotein, behaved as dominant negative on the proapoptotic function and nuclear localization of H4(D10S170). Furthermore, conditional expression of the H4(D10S170)-dominant negative truncated mutant protected cells from stress-induced apoptosis. The substitution of serine 244 with alanine abrogated the apoptotic function of H4(D10S170). These data suggest that loss of the H4(D10S170) gene function might have a role in thyroid carcinogenesis by impairing apoptosis.
Introduction
Approximately 20 000 new cases of thyroid carcinoma are diagnosed each year in the United States and benign conditions are even more frequent. Papillary thyroid carcinoma (PTC) is the most common thyroid malignancy; the biological behaviour of PTC varies widely from indolent microcarcinomas, growing slowly with little or no invasion, to invasive tumours that metastasize and can cause death. Since 1987, the identification of a new family of oncogenes in PTC has been reported (Fusco et al., 1987; Grieco et al., 1990) . These oncogenes, collectively named RET/PTC, were rearranged forms of the RET gene. RET encodes a tyrosine kinase membrane receptor for neurotrophic molecules of the glial cell line-derived neurotrophic factor (GDNF) family. In PTCs, chromosomal inversions or translocations lead to the recombination of the RET kinase domain with heterologous genes. Thus, RET/ PTC oncogenes code for fusion proteins that display constitutive kinase activity (Jhiang, 2000; Pierotti, 2001; Santoro et al., 2002) .
RET/PTC rearrangements are specific for thyroid carcinomas of papillary histotype and are considered early events in the tumorigenesis process because they are frequently found in clinically silent small PTCs (Viglietto et al., 1995) . Moreover, transgenic mice with thyroid-targeted expression of PTC1 developed thyroid carcinomas, indicating that the fusion plays a primary role in the pathogenesis of the disease with which it is associated (Portella et al., 1996) .
In thyroid tumours harbouring the RET/PTC1 rearrangement, activation of RET involves chromosomal inversion of the long arm of chromosome 10 that juxtaposes the tyrosine kinase-encoding domain of RET mapped at 10q11.2 to the promoter and the first exon of a new gene, H4(D10S170) gene, mapped at 10q21 (Pierotti et al., 1992) .
Cloning and sequencing of H4(D10S170) cDNA did not show any significant homology to known genes. Its predicted amino-acid (aa) sequence contains a long coiled-coil region and a putative binding domain for SH3-proteins, suggesting its possible involvement in protein-protein interactions . Indeed, a small part (60 aa) of the H4 coiled-coil domain included in the RET/PTC1 product has been shown to be necessary for its homodimerization, constitutive activation and transforming ability (Tong et al., 1997) .
It is not clear why RET/PTC1 has been found activated only in thyroid papillary carcinomas, since in vitro irradiation is able to induce its activation also in fibroblasts (Ito et al., 1993) .
Recently, Nikiforova et al. (2000) suggested that the spatial contiguity of RET and H4 chromosomal loci might be responsible for the high frequency of RET/ PTC1 radiation-induced rearrangements in thyroid human cells.
A new chromosomal rearrangement involving the H4(D10S170) gene has been recently described. In two cases of atypical chronic myelogeneous leukaemia (CML), the first 368 aa of H4(D10S170) fuse to the PDGFbR tyrosine kinase domain. The chromosomal event is a t(5;10) translocation. In the two cases of atypical CML in which the H4-PDGFbR transcript has been identified, the fusion gene codes for a 948 aa protein with most of the coiled-coil of H4(D10S170) and the transmembrane and the tyrosine kinase domains of the PDGFbR. The fusion protein oligomerization and constitutive activity is dependent on the coiled-coil domain of the H4(D10S170) gene. The reciprocal product of the translocation has not been found (Kulkarni et al., 2000; Schwaller et al., 2001) .
In the various RET/PTC oncoproteins, little is known about the normal role of the 5 0 fusion partners. Some common features such as constitutive expression and the presence of dimerization domains have been observed for all the RET-fused genes identified so far. The ubiquitously expressed promoters of the 5 0 -fused sequences are responsible for the ectopic expression of RET in epithelial thyroid follicular cells, which do not normally express this protooncogene.
Although this indicates that disruption of the normal regulation of the RET kinase is critical to the transforming properties, less is known about whether disruption of the normal function of the 5 0 partner gene might also have an important role. To address this point, the identification of the normal physiological function of the heterologous RET fusion partners is required. Therefore, we have characterized the product of the first and most frequently observed RET-fused gene, H4(D10S170).
In this paper, we show that H4(D10S170) is a phosphorylated protein localized both in the nucleus and in the cytosol. We demonstrate that H4(D10S170) phosphorylation is induced by serum, via ERK and is associated with changes in H4(D10S170) intracellular localization.
To help further unravel the function of H4(D10S170) and establish its role in the pathogenesis of papillary thyroid tumours, we restored H4(D10S170) expression in a human papillary thyroid cell line (TPC-1) that harbours the RET/PTC1 rearrangement and has lost the expression of the normal unrearranged H4(D10S170) allele. In this cell line we found that H4(D10S170) was able to induce apoptosis, while a truncated mutant H4(1-101) that corresponds to the portion of H4(D10S170) included in RET/PTC1, acted as dominant negative on wild-type (wt) H4(D10S170)-induced apoptosis. Moreover, this H4(D10S170) encoding portion of the RET/PTC1 oncogene H4(1-101) was able to protect from several stress agents able to induce thyroid cell death.
In conclusion, our results suggest that not only the RET kinase activity but also the inhibition of apoptosis resulting from the impairment of the H4(D10S170) gene function could play a role in the pathogenesis of PTCs harbouring RET/PTC1.
Materials and methods

Materials, antibodies
PD98059 (50 mM,) UO126 (10 mM), LY294002 (20 mM), SB202190 (500 nM), Bis-indolyl-maleimide (500 nM), were all purchased by Calbiochem.
Diethyl maleate (0.3-0.9 mM), Hydrogen peroxide (200-800 mM), TNFa (50 ng/ml), COCl 2 (100 mM), cycloheximide (1 mg/ml) were obtained from Sigma Chemical Co.
Mouse monoclonal antibody a-myc was purchased from Santa Cruz, rabbit polyclonal a-EGFP was obtained from Clontech, and rabbit polyclonal a-bcl-2, and a-bax were obtained from Oncogene Research. Monoclonal anti-tubulin was obtained from Sigma Chemical Co. (St Louis, MO, USA). Secondary antibodies were obtained from Santa Cruz Biotechnology.
Polyclonal anti-RET antibodies were raised using the kinase domain of the protein .
Cell culture and transfections
PC Cl3 cells were maintained in Coon's modified Ham's F12 medium (EuroClone) containing 5% calf serum (Gibco, Paisley/UK) plus six growth factors: thyrotropin, insulin, transferrin, hydrocortisone, somatostatin and glycyl-hystidyllysine. TPC-1 cells were maintained in Dulbecco's modified eagle's medium (Gibco) supplemented with 10% of FBS (Gibco, Paisley/UK). Doxycycline (doxy)-inducible expression based on the high specificity of the E. Coli tet repressor-operator-doxy interaction was obtained by using the T-REX System, InVitrogen. Stable transfections were performed by cotransfecting the pcDNA6/TR and the inducible expression constructs at a ratio of 6 : 1. After transfection, cells were treated with doxy to derepress the hybrid CMV/TetO2 promoter in the inducible expression vector and induce transcription of the gene of interest. The inducible expression plasmids H4wt and H4(1-101) were constructed by inserting, downstream of the CMVTetO2 promoter, in the BamHI-XhoI sites of pcDNA4-ToA/myc-His (T-Rex System, InVitrogen Corporation, San Diego, CA, USA) two PCR fragments corresponding, respectively, to the entire coding sequence (nt 1-1791, H4wt) and to a truncated form (nt 1-101, H4(1-101)) of H4(D10S170) gene. All the constructs were verified by sequence.
We inserted in the NheI-BamHI sites of EGFP N1 (Clontech) the PCR products of H4wt and H4(1-101).
The RET/PTC1 construct is described elsewhere (Melillo et al., 2001) .
Transfections were performed using the calcium phosphate precipitation method (Graham and van der Eb, 1973) .
For transient transfection assays, 10 Â 10 6 of TPC-1 and PC Cl3 cells were electroporated at 300 mV, 960mFD in a buffer for electroporation (pH 7.4, 20 mM HEPES, 137 mM NaCl, 5 mM KCl, 0.7 mM Na 2 HPO 4 /NaH 2 HPO 4 , 6mM glucose).
Antibody production
The H4(D10S170) cDNA fragment corresponding to nt 1231-1428 was amplified by PCR using the oligonucleotides GGGGATCCGTGCAGCAC (sense) and GGAATTCTGC-GAAGGA (antisense) and subcloned in the BamHI-EcoRI sites of pGEX2T. The resulting GST fusion protein (GSTH4Prol) was produced in BL21 bacteria, purified by glutathione-agarose beads and subcutaneously injected (100 mg) with complete Freund's adjuvant in rabbits following standard procedures. After four boost injections at 3-week time intervals, serum was collected and affinity purified against GST and GSTH4Prol.
Western blotting
The indicated amount of proteins from total cell lysate, treated with or without doxy, were subjected to SDS-PAGE and Western blotting as described (Laemli, 1970; Towbin et al., 1979) .
Blots were hybridized with antibodies to the indicated proteins and then with their corresponding species-specific horseradish peroxidase-conjugated secondary IgG and visualized using the ECL chemiluminescence system (Amersham/ Pharmacia).
DNA fragmentation
Cells were incubated for the indicated times and the attached cells were collected by trypsinization and combined with the detached cells suspended in the medium. DNA was then extracted and 20 mg from each sample was electrophoresed through a 2% agarose-TBE gel and the DNA visualized by staining with ethidium bromide.
MTT colorimetric assays
To determine cell viability, an MTT assay was performed as directed by the manufacturer (Roche). Briefly, the medium was removed from the cells and replaced with a fresh medium containing 0.5 mg/ml 3-(4,5-dimethylthiazol-2yl)-2-5-diphenyltetrazolium bromide (MTT) (Roche, 1 465 007) and incubated for 3 h at 371C. The medium was removed and the coloured precipitate formed by cleavage of MTT in living cells was solubilized with isopropyl alcohol containing 0.05 M HCl. Cell survival was determined by absorbance at 570 nm. The background was determined by absorbance at 690 nm.
Confocal laser and TUNEL analysis
EGFP staining was examined using a Leica TCS SP II scanning confocal microscope equipped with an argonkrypton laser.
TUNEL analysis was performed using the 'In Situ Cell Death Detection kit, TMR red' (Roche, cat no. 2 156 792). TUNEL reactivity was examined and photographed with a Zeiss Axioskop photomicroscope. The number of TUNELpositive cells was estimated by counting at least 100 TUNELpositive EGFP-expressing cells from six separate fields.
Flow cytometry
Cells were harvested when the subconfluent, fixed in ethanol for 1 h at À201C, was rehydrated in PBS for 1 h at 41C, and then treated with RNase A (100 U/ml) for 30 min. Propidium iodide (25 mg/ml) was added to the cells for 30 min in the dark. Samples were analysed with a FACScan flow cytometer (Becton Dickinson, San Jose, CA, USA) using an argon-ion laser tuned to 488 nm measuring forward and orthogonal light scatter, and red fluorescence measuring area and either peak of the fluorescent signal. Data were acquired using CellQuest s software and analysed with Modfit s software.
Site-directed mutagenesis
Several green fluorescent protein (GFPH4wt) single mutants at serine or threonine putative phosphorylation sites were created using the QuickChange site-directed mutagenesis system from Stratagene. Hence,
), and GFPH4Ser431(Ala431), (H4 S431A ), were constructed using GFPH4wt as a template and the following primers:
To obtain the mycH4 S244A we used the S244A primers on the pcDNA4ToA-H4wt template.
To generate the full-length GFPH4Thr357(Ala357), (H 4 T357A ), and the GFPH4Thr427(Ala427), ( H4 T427A ), we used the same template and the following primers:
Results
H4(D10S170) is a phosphorylated protein
To study the H4(D10S170) function, we produced a specific polyclonal antibody directed against its carboxyterminus, a-H4. The antibody was affinity purified and its specificity was verified by testing an H4(D10S170)-null cell line versus other H4(D10S170)-expressing cell lines (data not shown; Cerrato A et al., manuscript submitted). As shown in Figure 1a , this antibody was able to detect a major 55 KDa band by Western blot as expected by the primary sequence predicted molecular protein mass. After serum addition, an additional slowly migrating band was detected, starting at 30 min and lasting up to 24 h. Calf intestinal alkaline phosphatase (CIAP) treatment at 5 and 24 h determined a significant decrease of the upper band, thus suggesting that the serum-induced modification depended on phosphorylation.
Orthophosphate 32P labelling of cells followed by immunoprecipitation with a-H4 antibodies confirmed that H4(D10S170) is a phosphoprotein (Figure 1b , lane 1). After serum stimulation a reinforcement of the upper band was appreciated ( Figure 1b , lane 2). Thus these results indicate that the H4(D10S170) gene product is a phosphoprotein whose post-translational modification is serum induced.
H4 phosphorylation is ERK dependent
A search for putative H4(D10S170) phosphorylation sites was performed by the program Motif Scan (http:// scansite.mit.edu/): several consensus for putative phosphorylation sites at serine and threonine residues were detected and in particular four ERK1 kinase sites at position 244, 431, 357, and 427, two AKT kinase sites at position 351 and 349, one PKC mu site at position 480; no PKC a/b/g and z sites and no p38 mitogen-activated protein kinase (MAPK) sites were predicted.
To single out the kinases able to phosphorylate the H4(D10S170) protein in the presence of serum, we tested some protein kinase inhibitors: starved cells were pretreated 2 h before serum stimulation with drugs, known to inhibit specifically one of these pathways: MEK1/2, p38MAPK, PKC and PI3 kinase pathway. Only PD98059 and U0126, (MEK1/2-specific inhibitors), but not Bis-indolyl-maleimide (PKC-specific), LY294002 (PI3-kinase specific) or SB202190 (p38MAPK-specific) were able to block serum-induced H4(D10S170) phosphorylation (Figure 1c ), thus suggesting that the serum-induced post-translational modification of the H4(D10S170) gene product is dependent on ERK activity.
S244 is the major target residue of ERK1
The four ERK1 kinase sites, predicted by the H4(D10S170) protein sequence, share the consensus motif PXSTP. Of these ERK1 putative sites, the phosphorylation residue at position 244 is present in the predicted primary aa sequence of the H4(D10S170) homologous gene of Xenopus laevis (Accession no. AAH45133), of mouse (Accession no. XP_284873), in two highly homologous genes from Drosophila melanogaster (Accession no. AAN71041 and Accession no. AAF49384) and in the homologue of Anopheles gambiae (Accession no. EAA11792). The conservation of H4(D10S170) in phylogenesis suggests that this gene might be involved in a conserved pathway and that this consensus site might have an important functional role.
By site-directed mutagenesis, we generated H4 (D10S170) single point mutants for each of the four ERK1 putative phosphorylation sites, i.e. serine 244, serine 431, threonine 357 and threonine 427. These mutants were inserted into CMV-driven eukaryotic expression vectors and transfected in 293 cells to analyse As shown in Figure 1d , in transfected 293 starved cells a reinforcement of the upper band was also observed for the wt protein after serum stimulation; the pretreatment of the cells with the MEK inhibitor, U0126, inhibited this modification (Figure 1d, H4wt) . Conversely, after serum stimulation the H4(D10S170) serine 244 to alanine single point mutant ( H4 S244A ) showed a significant decrease of the upper phosphorylated band compared to the H4(D10S170) mutants at the other putative site of phosphorylation (H4T357A, H4T427A, H4S431A), which showed the same behaviour of the H4(D10S170) wt protein at electrophoretic migration. (We show in Figure 1d , the behaviour of S431, as an example.)
Overexpression of a constitutively active MEK1 mutant (MEKSS217-221DD) (Alessi et al., 1994) determined the phosphorylation of H4(D10S170) wt protein in the absence of serum but had no effect on the H4S244A mutant gene product (Figure 1e ).
Taken together, these data suggest that S244 is the major serum-induced phosphorylation site and that it is the major target of ERK-kinase activity.
H4 is a nuclear and cytosolic protein
To investigate the intracellular localization of the H4(D10S170) gene product, we performed immunofluorescence studies with a-H4 on several cell lines. A nuclear and cytosolic signal was observed in all the cells tested by confocal laser microscopy, showing some variation in the nuclear/cytosolic ratio following serum stimulation. The same results ( Figure 2a ) were obtained in a human thyroid papillary carcinoma cell line, established from a tumour carrying the RET/PTC1 oncogene activation, named TPC-1. It has been shown that these cells have lost by deletion the wt H4(D10S170) allele not involved in the rearrangement with RET (Jossart et al., 1996) .
TPC-1 cells starved from serum and expressing a GFP-fusion H4(D10S170) construct (GFPH4wt) showed a predominant nuclear signal, while fluorescence was mostly cytosolic after serum stimulation (Figure 2b) . The same serum-induced change in intracellular localization was observed in other GFPH4wt-transfected cell lines such as the NIH3T3, PC Cl3 rat thyroid epithelial cell line and Hela cells. No changes in intracellular localization were observed in control GFP-transfected cells after serum addition (Figure 2c ).
To determine if the intracellular redistribution of H4(D10S170) gene product upon serum stimulation was ERK1 dependent, we investigated the effect of S244A was found to be both nuclear and cytosolic, as the wt protein, but after serum stimulation the mutant did not modify its intracellular localization (Figure 2d) . Thus, ERK-dependent H4 phosphorylation at S244 is necessary for its intracellular redistribution upon serum stimulation.
H4(D10S170) induces apoptosis
On performing the above-mentioned experiments we noticed that transient transfection of the GFP-tagged H4(D10S170) construct induced suffering of the cells in higher percentage than the control mock-transfected cells, as evaluated by the vital dye exclusion test and MTT. As shown in Figure 3a (column 2), after 16 h of transfection, 38% of cell death was detected in the H4(D10S170)-transfected population as evaluated by MTT. A background level of 3% dead cells was detected in the mock plasmid-transfected control (Figure 3a) . The morphology of the cells at phase contrast microscopy suggested cellular alteration reminiscent of apoptosis such as rounding up, membrane blebbing and chromatin condensation (data not shown). To verify whether these changes were signs of apoptosis, we performed a TUNEL assay on H4(D10S170) expressing cells.
TUNEL confirmed MTT data showing 40% of apoptosis in TPC-1 cells expressing GFP-tagged H4(D10S170) as measured counting TUNEL-positive nuclei (TMR-dUTP, red) in GFP-positive cells (Figure 3b ). In TPC-1 cells transfected with GFP-tagged H4(D10S170) cDNA, but not with the GFP vector, only DNA fragmentation was detected ( Figure 3c ). As additional evidences of apoptosis, we found that the addition of the caspase-3 inhibitor Z-VAD to the transfected cells blocked cell death as evaluated by MTT (Figure 3a ) and TUNEL assay (Figure 3b) .
Therefore, it could be concluded that enforced H4(D10S170) expression in a H4(D10S170)-null cell line (TPC-1) induced apoptosis.
The proapoptotic effect was not predicted by the analysis of the aa primary sequence since no known apoptosis-related domains were present.
The truncated mutant H4(1-101) acts as dominant negative on apoptosis
The small part of the coiled-coil domain included in the portion of H4(D10S170) present in RET/PTC1 has been reported to be necessary for homodimerization of the RET/PTC1 oncoprotein and to be essential for its transforming ability (Tong et al., 1997) . Then we hypothesized that the truncated mutant H4(1-101) by forming heterodimers with the endogenous H4(D10S170) wt protein might be able to modulate both the localization and the proapoptotic function of We generated a GFP-tagged construct corresponding to the first 101 aa of H4(D10S170) fused to RET in RET/PTC1 H4(1-101) (Figure 4a ). Different from the wt protein, located both in the nucleus and in the cytosol, the expression of the H4(1-101) deletion mutant protein was found exclusively in the cytosol, thus suggesting that the putative signals responsible for H4 nuclear localization are located outside of this part of the protein (Figure 4b) . Moreover, the expression of this deletion mutant in TPC-1 cells was unable to induce apoptosis as shown by MTT and TUNEL analyses (Figure 4c and d) . In fact, H4(1-101)-transfected TPC-1 cells showed a high rate of survival (97%) similar to the control cells expressing only the empty vector.
Thus, since H4(1-101) deletion mutant showed a different intracellular distribution and a lack of proapoptotic function in comparison to the H4(D10S170) wt protein, it seems very likely that heterodimers between these two proteins might have a different intracellular location and be unable to induce apoptosis.
To confirm that H4(1-101) was able to form heterodimers with H4(D10S170) wt, 293 cells were transiently transfected with expression plasmids for a myc epitope-tagged H4(1-101) together with GFPtagged H4wt (GFPH4wt). 293 cells protein lysates were then immunoprecipitated with anti-myc Mab and blotted with anti-GFP or anti-myc Mab.
As shown in Figure 5a , H4wt was efficiently coimmunoprecipitated with H4(1-101) whereas the control GFP-empty vector was not coprecipitated (Figure 5a ). Moreover, H4wt, forming heterodimers with the truncated mutant H4(1-101), was not phosphorylated after serum addition (Figure 5b) .
We then tested if this construct was able to modulate H4wt intracellular localization. Therefore, we transfected TPC-1 cells with both GFP-tagged H4(D10S170) and myc-tagged H4(1-101). In the presence of the truncated protein H4(D10S170) wt was delocalized into the cytoplasm (Figure 5c ) thus indicating that the heterodimerization between the truncated mutant and the wt protein was able to retain the wt protein in the cytoplasm.
Since the mutant H4(1-101) behaved as dominant negative on the wt protein localization, we investigated its effects on survival and apoptosis. By MTT analysis we compared the survival of the cells overexpressing GFPH4wt together with the mycH4 (1-101): the cotransfection of the two forms of H4 (wt and truncated mutant) conferred to the cells a high rate of survival (97%) (Figure 5d ) in comparison to the controls (i.e. H4wt or H4(1-101) transfected alone).
A drastic reduction of the apoptosis induced by H4wt was observed in the presence of its truncated form: TUNEL assay of TPC-1 cells transfected with H4wt together with H4(1-101) (Figure 5c ) showed no staining of GFPH4 wt expressing cells.
S244A mutant is unable to induce apoptosis and acts as a dominant negative
Our previous results showing that H4(D10S170) is able to induce apoptosis and that nuclear localization of its product is necessary for this function to occur suggested that serum-induced H4(D10S170) phosphorylation might be a required step for the induction of apoptosis.
Therefore we tested the S244A mutant for its ability to induce programmed cell death by enforced expression in TPC-1 cells. As shown in Figure 3 , no apoptosis was induced by this construct as evaluated by MTT (Figure 3a) and TUNEL ( Figure 3b ).
As shown in Figure 5e , this single point mutant was able to coimmunoprecipitate efficiently the wt H4(D10S170) protein by inactive mutant, thus indicating that phosphorylation might not be required for the formation of heterodimers.
Based on this observation, which suggests the possibility of a dominant-negative effect also for this mutant, we next tested its ability to interfere with H4(D10S170)-induced apoptosis. As shown in Figure   Figure 5 
Conditional expression of H4(1-101) protects thyroid cells by several apoptotic agents
In order to characterize the apoptotic function exerted by H4(D10S170) better, we decided to establish a conditional expression system in the rat epithelium thyroid cell line PC Cl3. PC Cl3 is a widely used model system for studying thyroid cell physiology since they retain differentiation markers and depend for growth on a mixture of six hormones, including TSH and insulin (Fusco et al., 1987) .
We used a Tet-on system that allows a robust and tightly controlled expression of the gene of interest upon the addition of doxy to the cell culture medium (Baron and Bujard, 2000) . The appropriate vectors were generated to express myc-tagged H4wt and H4(1-101) proteins. Several clones expressing the proteins only in the presence of doxy were selected. Three different clones for each construct were further studied. Western blot with anti-myc antibody showed the right size of induced proteins (Figure 6a) . A measure of 1 mg/ml of doxy was sufficient to obtain the maximal expression of both proteins already at 24 h. Having established a conditional expression cell system for both H4wt and H4(1-101), we tested the ability of these constructs to induce apoptosis in the PC Cl3 cell line. Also, in these cells we observed that the doxy-induced expression of the full-length protein was able to induce a 35% of apoptosis as shown by the presence of sub-G1 peak at FACS analysis (Figure 6b ) and by TUNEL assay (not shown). Similar results were obtained for all the clones selected. Conversely, H4(1-101) constructs were unable to induce cell death behaving as the control empty vector.
To gain insight into H4(D10S170)-mediated apoptosis we investigated the expression levels of the antiapoptotic protein Bcl-2 and the proapoptotic protein Bax by immunoblot: in PC Cl3 cells Tet-induced H4wt expression at 24 h showed increased levels of Bax and a reduced level of Bcl2, in comparison to uninduced protein and to the mock transfectants (Figure 6c) .
To characterize our model cell system further with regard to the ability to respond correctly to proapoptotic stimuli, we tested the apoptosis induced by stress agents, hypoxic agents and death cytokines. As shown in Figure 7a all these agents were able to induce programmed cell death in all the selected clones in the absence of doxy. Therefore, we investigated if induction of H4(1-101) was able to prevent apoptosis induced by these agents.
Tet-inducible H4(1-101) expression protected the cells from apoptosis induced by Diethyl-maleate (DEM) treatment at 0.9 mM, by H 2 O 2 treatment at 600 mM, by COCl 2 treatment at 100 mM and by TNFa treatment at 50 ng/ml for 8 h as shown by TUNEL assay (Figure 7a and b) .
The addition of doxy to the PC Cl3 TetH4(1-101) cells preventing the cells from stress agent-or death cytokines-induced apoptosis attenuated the expression of Bax, and rehabilitated the level of Bcl2 (data not shown). These findings therefore indicate that H4(1-101) exerts a significant protection against apoptosis, possibly by stabilizing the Bax/Bcl2 protein ratio.
Discussion
In the present study, we have characterized the product of H4(D10170), a gene undergoing gene rearrangements in thyroid papillary carcinomas and in chronic myelomonocytic leukaemia (Grieco et al., 1990; Kulkarni et al., 2000; Schwaller et al., 2001) . Both thyroid and haematopoietic tissues are very sensitive to the effects of ionizing radiations (Ito et al., 1993; Bounacer et al., 1997a, b; Schlumberger et al., 1999; Mizuno et al., 2000; Rabes et al., 2000; Tuttle and Becker, 2000; Moysich The possible role exerted by the H4(D10S170) gene in carcinogenesis has been partially explored: it was reported that part of this gene product present in RET/PTC1 was responsible for the dimerization of the RET tyrosine kinase thus resulting in its constitutive activation (Tong et al., 1997) . The mechanism of transformation for H4/PDGFRb has also been ascribed to constitutive activation of the receptor, which is dependent from portions of the H4(D10S170) coiledcoil domain contained in the oncogene (Schwaller et al., 2001) . Both RET/PTC1 and H4/PFGFRb fusion proteins were shown to depend on their tyrosine kinase activity for the induction of cell transformation (Salvatore et al., 2000; Melillo et al., 2001; Schwaller et al., 2001) . Therefore, the possible role exerted by their common fusion partner H4(D10S170) has been so far restricted to inducing constitutive activation of the tyrosine kinase domains of the fusion proteins and full transforming activity has been mainly ascribed to their deregulated signalling.
However, since no function was known for H4(D10170), other possible mechanisms leading to thyroid and haematopoietic cancer could not be ruled out.
The major finding of our present study is the identification of an unexpected proapoptotic activity exerted by H4(D10170), as no putative proapoptotic features were detected in H4(D10S170) primary aa sequence and no homologies were found with other apoptosis-related genes . We showed that the enforced expression of H4(D10S170) was able to induce apoptosis in thyroid follicular cell lines. The identification of this H4(D10S170) function might suggest a new apoptotic pathway mediated by a new class of gene products.
As H4-predicted aa sequence contains a long coiledcoil region we cannot exclude nonphysiological interactions following overexpression of the wt protein. Nevertheless, the truncated H4(D10S170) product corresponding to the portion contained in RET/PTC1 was able to act as a dominant negative on the proapoptotic activity of H4(D10S170) and to inhibit stress-induced apoptosis in a conditional expression system. The proapoptotic effect of H4(D10S170) and the antiapoptotic effect exerted by its negative-dominant mutant are convergent results that make it very unlikely that these effects could be due to aspecific interactions caused by overexpression.
Apoptosis induction by H4(D10S170) was shown to be inhibited by a general upstream caspase inhibitor and associated with Bax upregulation and Bcl2 downregulation.
The H4(D10S170) gene product was located both in the cytoplasm and in the nucleus, and was found to be phosphorylated upon serum stimulation. By means of protein kinase inhibitors we have demonstrated that H4(D10S170) phosphorylation is ERK1 dependent. Analysis of point mutants in putative MAPK target residues demonstrated that S244 is the major site for this ERK1-dependent phosphorylation. This aa residue is embedded in the sequence (PXS/TP) and is located downstream the H4(D10S170) breakpoint generating RET/PTC1 oncogenes. This residue is also conserved in the course of the phylogenesis. No proapoptotic function was observed for the S244 point mutant, thus suggesting that the H4(D10S170) protein phosphorylation by ERK1 is required for H4(D10S170)-induced apoptosis to occur. This was also suggested by the negative dominance exerted by the S244 point mutant on the H4(D10S170) proapoptotic activity. No apoptosis was also observed by the overexpression of the H4(D10S170) truncated form corresponding to the portion of the protein included in RET/PTC1, while a negative-dominant effect on apoptosis was exerted by overexpressing this fragment together with the fulllength H4(D10S170) protein. These data suggest that the proapoptotic function requires the formation of homodimers composed of full-length, ERK-phosphorylated H4(D10S170) proteins and that heterodimers are not able to exert this function. ERK-dependent apoptosis was reported following DNA damage by a number of stimuli including ionizing radiation (Tang et al., 2002) . The activation of ERK by DNA damage was shown to be dependent on the ATM kinase (Tang et al., 2002) , the best characterized transducer of DNA damage (Bouillet and Strasser, 2002) . Our data on the ERK dependence of H4(D10S170)-induced apoptosis and the high frequency of H4(D10S170) rearrangements in radiation-induced thyroid tumours might suggest that this gene product could be involved in ATM-dependent DNA damage response. Two putative ATM phosphorylation sites might be present in H4(D10S170) as predicted by ProfileScan primary sequence analysis, and also conserved in the various species in which H4(D10S170) is present, thus suggesting that H4(D10S170) might be a direct target of ATM. Experiments are in progress to test this hypothesis.
Our data showing Bax upregulation and Bcl2 downregulation following conditional overexpression of H4(D10170), together with the observation of the negative dominance exerted by its truncated form on stress-and TNFa-induced cell death, might suggest that this gene functions downstream the major apoptotic signalling pathways. Bax, a proapoptotic member of the Bcl-2 family, whose cell death-promoting activity is antagonized by bcl-2, has been reported to be induced by ionizing radiation in a p53-dependent manner (Zhan et al., 1994) . Bax overexpression enhances radiationinduced apoptosis (Sakakura et al., 1996) and can be induced both in a p53-dependent and a p53-independent manner (Butt et al., 2000; Mitchell et al., 2000) . H4(D10S170)-induced increase in Bax protein levels might be the result of p53 activation. At variance with the normal unrearranged gene product, the truncated H4(D10S170) protein corresponding to the portion contained in RET/PTC1 was located in the cytoplasm and was not able to migrate into the nucleus. Given the ability of this part of the protein to form heterodimers with the unrearranged wt H4(D10S170) gene product and to affect the phosphorylation status of the wt protein, our data showing the delocalization from the nucleus to the cytoplasm of the unrearranged H4(D10S170) in the presence of its truncated form suggest that RET/PTC1 could interfere with H4(D10S170) gene function and that nuclear localization is required. A group of pathologists have reported that 90% of RET/PTC1 positive thyroid tumours fail to express the unrearranged allele of H4(D10S170) (Sheils et al., 2000) . The same phenomenon has been observed in the TPC-1 thyroid papillary carcinoma cell line, a line harbouring RET/PTC1 oncogene activation that has been reported to have a gene deletion encompassing the normal H4(D10S170) allele (Jossart et al., 1996) . Taken together, these data suggest that the presence of the unrearranged normal H4(D10S170) gene product could exert a negative action on cell proliferation and that a growth advantage might result from the loss of the normal allele of this gene, likely during tumour progression.
It has been shown recently that RET/PTC1 and RET/ PTC3 are able to promote thyroid cell death depending on the tyrosine kinase activity of RET (Castellone et al., 2003 , Wang et al., 2003 . Thus RET/PTC1, whose proapoptotic activity was dependent on ERK activation, might be able to exert a dual action: one promoting cell proliferation and the other promoting cell death. Our data showing a role in apoptosis induction exerted by H4(D10S170) and the ability of its truncated form to rescue the cells by stress-induced apoptosis suggest an explanation for the reported loss of H4(D10S170) expression in thyroid papillary carcinomas. In the tumour initiation RET/PTC1, which is able to form heterodimers with H4wt (Figure 8a ), might be able to modulate H4(D10S170) proapoptotic function negatively (Figure 8b) . Therefore, the generation of RET/PTC1 and the loss of H4(D10S170) function might have a synergistic effect resulting in the impairment of apoptosis in thyroid cancer cells.
Considering the high frequency of gene rearrangements involving H4(D10S170) in neoplasia, the identification of the involvement of this gene in apoptosis and the future identification of the pathway involved will be useful for the establishment of new therapeutic approaches based on the modulation of apoptosis. 
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